The size of the Electrophoresis Market in the Asia Pacific is estimated to be growing at a CAGR of 6.72% to reach USD 0.5 billion by 2024 from USD 0.36 billion in 2019 during the forecast period 2019 - 2024.
Electrophoresis is used in DNA Analysis. DNA is notable for its consistency of negative charge, which implies that electric current applies roughly equal force to any portion of DNA, which separates larger and smaller fragments of DNA due to the effect of friction from test medium. The medium is generally made of agarose gel or acrylamide gel which freezes the separated fragments enabling them to be examined at high resolutions. Electrophoresis is the motion of dispersed particles relative to a fluid under a uniform electric field applied spatially.
Major driving forces of the market are growing focus on next-generation sequencing (NGS), rising funding for electrophoresis techniques, rising incidences of chronic diseases, cancer, and genetic disorders. The growing number of industry-academia research collaborations and growing funding for research on genomic and proteomic techniques will also assist in the growth of the market.
Yet, electrophoresis techniques are time-consuming operations and offer limited sample analysis and the presence of alternative technologies to electrophoresis may hamper the growth of the market.
This research report segmented and sub-segmented the Asia Pacific Electrophoresis Market into the following categories:
Key Companies dominating this Asia Pacific Electrophoresis Market Profiled in the Report are Bio-Rad Laboratories, GE Healthcare, Thermo Fisher Scientific Inc, Danaher Corporation, Agilent Technologies, Merck Millipore, PerkinElmer, QIAGEN N.V., Lonza Group Ltd., Shimadzu Corporation, Harvard Bioscience, Sebia Group and C.B.S. Scientific Company
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Gel Electrophoresis
5.1.2.1 Gel Electrophoresis by Instrument type
5.1.2.1.1 Horizontal Gel Electrophoresis
5.1.2.1.2 Vertical Gel Electrophoresis
5.1.2.1.2.1 1d Gel Electrophoresis
5.1.2.1.2.2 2d Gel Electrophoresis
5.1.2.2 Gel Electrophoresis by Gel type
5.1.2.2.1 Agarose Gel Electrophoresis
5.1.2.2.2 Polyacrylamide Gel Electrophoresis
5.1.3 Capillary Electrophoresis
5.1.3.1 Capillary Zone Electrophoresis
5.1.3.2 Capillary Gel Electrophoresis
5.1.3.3 Capillary Isoelectric Focusing
5.1.3.4 Micellar Electrokinetic Capillary Chromatography
5.1.3.5 Capillary Isotachophoresis
5.1.3.6 Capillary Electrochromatography
5.1.4 Geldoc
5.1.5 Imaging
5.1.6 Y-o-Y Growth Analysis, By Product
5.1.7 Market Attractiveness Analysis, By Product
5.1.8 Market Share Analysis, By Product
5.2 Application
5.2.1 Introduction
5.2.2 Diagnostics Development
5.2.3 Research and Development
5.2.4 Quality Control
5.2.5 Other Applications
5.2.6 Y-o-Y Growth Analysis, By Application
5.2.7 Market Attractiveness Analysis, By Application
5.2.8 Market Share Analysis, By Application
5.3 End Users
5.3.1 Introduction
5.3.2 Academic and Research Institutes
5.3.3 Pharmaceutical & Biotechnology Companies
5.3.4 Hospitals & Diagnostic Centers
5.3.5 Others
5.3.6 Y-o-Y Growth Analysis, By End Users
5.3.7 Market Attractiveness Analysis, By End Users
5.3.8 Market Share Analysis, By End Users
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Application
6.1.3.4 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Application
6.1.4.4 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Application
6.1.5.4 By End User
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Bio-Rad Laboratories
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 GE Healthcare
8.3 Thermo Fisher Scientific Inc
8.4 Danaher Corporation
8.5 Agilent Technologies
8.6 Merck Millipore
8.7 PerkinElmer
8.8 QIAGEN N.V.
8.9 Lonza Group Ltd
8.10 Shimadzu Corporation
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
